Table 2

Clinical characteristics and outcomes of patients in high and low COVID-19 counties

Thrombectomy patients in high COVID-19 burden counties (n=104)Thrombectomy patients in low COVID-19 counties (n=354)P-value*
Age, median (IQR)70 (58–78)72 (60–80)0.219
Females, n (%)46 (44.2%)164 (46.3%)0.706
White, n (%)71 (68.3%)239 (67.5%)0.885
LKN to hospital door, median (IQR)286 (144–639)255 (105–490)0.262
Admission NIHSS, median (IQR)15 (11–20)16 (10–21)0.491
IV-tPA, n (%)29 (27.9%)155 (43.8%) 0.004
ASPECTS, median (IQR)†9 (8–10)8 (7–10)0.063
Posterior circulation, n (%)8 (7.7%)38 (10.7%)0.364
Intubation, n (%)38 (36.5%)203 (57.3%) <0.001
Door to groin, median (IQR)68 (36–123)85 (54–127)0.054
LKN to groin, median (IQR)350 (195–686)352 (200–651)0.529
Number of passes, median (IQR)2 (1–3)2 (1–3)0.395
mTICI ≥2 b, n (%)83 (79.8%)298 (84.2%)0.294
Procedure duration, median (IQR)35 (23–62)41 (25–69)0.177
Door to reperfusion, median (IQR)111 (60–188)127 (79–176)0.221
Length of stay, median (IQR)5 (3–10)6 (3–10)0.387
DC mRS, median (IQR)‡4 (2–6)4 (2–5)0.713
Functional independence at discharge (mRS 0–2), n (%)‡23 (30.7%)73 (28.7%)0.747
sICH, n (%)9 (8.7%)19 (5.4%)0.219
  • *Calculated using chi-square test for categorical variables and Wilcoxon test for the continuous variables.

  • †Only for patients with anterior circulation occlusion.

  • ‡Missing for 130 patients.

  • ASPECTS, Alberta Stroke Program Early CT score; COVID-19, coronavirus disease of 2019; DC, discharge; IV-tPA, intravenous tissue plasminogen activator; LKN, last known normal; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institute of Health Stroke Scale; sICH, symptomatic intracerebral hematoma.